---
title: "Haleon plc (HLN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/HLN.US.md"
symbol: "HLN.US"
name: "Haleon plc"
industry: "Pharmaceuticals"
---

# Haleon plc (HLN.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.haleon.com](https://www.haleon.com) |

## Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth ...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:11.000Z

**Overall: C (0.46)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 46 / 189 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.45% |  |
| Net Profit YoY | 46.42% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.28 |  |
| Dividend Ratio | 1.62% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 49.88B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 14.49B |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.35% | B |
| Profit Margin | 13.81% | B |
| Gross Margin | 64.51% | A |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.45% | C |
| Net Profit YoY | 46.42% | B |
| Total Assets YoY | 3.34% | C |
| Net Assets YoY | 3.83% | C |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 723.98% | B |
| OCF YoY | 2.45% | C |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.34 | D |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 49.74% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Haleon plc",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.35%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "13.81%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "64.51%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "2.45%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "46.42%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "3.34%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "3.83%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "723.98%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "2.45%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.34",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "49.74%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Eli Lilly (US.LLY) | A | A | B | E | B | B |
| 02 | ROCHE HOLDINGS AG (US.RHHVF) | A | B | B | D | C | B |
| 03 | Roche (US.RHHBY) | A | B | B | D | C | B |
| 04 | AstraZeneca (US.AZN) | A | B | C | D | C | B |
| 05 | NOVARTIS AG (US.NVS) | A | B | C | D | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 24.92 | 38/256 | 25.46 | 23.07 | 21.29 |
| PB | 2.28 | 98/256 | 2.30 | 2.07 | 1.95 |
| PS (TTM) | 3.44 | 81/256 | 3.27 | 3.09 | 2.93 |
| Dividend Yield | 1.62% | 23/256 | 1.89% | 1.79% | 1.56% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-22T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 25% |
| Overweight | 2 | 50% |
| Hold | 1 | 25% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 11.23 |
| Highest Target | 13.44 |
| Lowest Target | 10.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/HLN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/HLN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/HLN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.